Your session is about to expire
← Back to Search
AdVEGFXC1 for Angina (EXACT Trial)
EXACT Trial Summary
This trial is testing a new treatment for angina caused by coronary artery disease. The treatment is a gene therapy that is delivered directly to the heart muscle. The goal is to see if the treatment is safe and if it can improve the patient's condition.
- Refractory Angina
- Coronary Artery Disease
- Cardiovascular Disease
- Heart Disease
- Ischemia
EXACT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowEXACT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.EXACT Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research program accommodate individuals beyond the age of 35?
"This clinical study is seeking participants aged 18-80 inclusively."
Who meets the criteria to be considered a participant in this trial?
"The study is looking for 41 coronary artery disease sufferers between the legal age of consent and 80 years old. Eligible applicants must also meet additional criteria, such as being a male or female with adequate contraception if they are capable of childbirth."
Are there any active recruitment efforts for this investigation?
"This research trial is not presently accepting participants. As it was initially uploaded to clinicaltrials.gov on the 24th of January 2020, and most recently updated on July 7th 2022, this indicates that patient recruitment has concluded. However, there are still 1478 other medical studies actively seeking volunteers at present time."
How many medical centers are currently hosting this research study?
"As of now, 17 medical facilities are hosting this trial. Locations include Allentown, Phoenix and Houston among others. It is imperative to choose the closest clinic in order to reduce travel-related strain should you decide to participate."
Share this study with friends
Copy Link
Messenger